Revolution Medicines Inc annual net income for fiscal TTM was -$1.4 billion, a decrease of 21.3% from -$1.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($1.4B) | ($1.1B) | ($600M) | ($436M) | ($249M) | ($187M) | ($108M) | ($48M) | ($42M) | ($31M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | ($454M) | ($365M) | ($305M) | ($248M) | ($213M) | ($195M) | ($156M) | ($133M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RVMD metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All RVMD financial statements → Interactive RVMD charts →
About TickerBase · Data methodology & sources